• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型酪氨酸激酶生长因子受体表皮生长因子受体、c-erbB2和c-erbB3在膀胱癌中的表达。

Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.

作者信息

Rajkumar T, Stamp G W, Pandha H S, Waxman J, Gullick W J

机构信息

ICRF Oncology Unit, Royal Postgraduate Medical School, London, UK.

出版信息

J Pathol. 1996 Aug;179(4):381-5. doi: 10.1002/(SICI)1096-9896(199608)179:4<381::AID-PATH603>3.0.CO;2-X.

DOI:10.1002/(SICI)1096-9896(199608)179:4<381::AID-PATH603>3.0.CO;2-X
PMID:8869284
Abstract

Expression of the c-erbB3 protein was determined in transitional cell carcinoma of the bladder by immunohistochemistry. Strong membrane staining was observed in 10 per cent of cases (7/70) and cytoplasmic and membrane overexpression in 20 per cent (14/70). Overexpression of the epidermal growth factor (EGF) receptor (36 per cent, 25/70) and c-erbB2 proteins (9 per cent 6/70) was determined in the same series of cases. c-erbB3 overexpression was positively correlated with EGF receptor expression (P < 0.025) but appeared to be inversely associated with c-erbB2 overexpression.

摘要

通过免疫组织化学法测定膀胱移行细胞癌中c-erbB3蛋白的表达。在10%的病例(7/70)中观察到强膜染色,在20%(14/70)的病例中观察到细胞质和膜的过表达。在同一组病例中测定了表皮生长因子(EGF)受体(36%,25/70)和c-erbB2蛋白(9%,6/70)的过表达。c-erbB3过表达与EGF受体表达呈正相关(P < 0.025),但似乎与c-erbB2过表达呈负相关。

相似文献

1
Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.1型酪氨酸激酶生长因子受体表皮生长因子受体、c-erbB2和c-erbB3在膀胱癌中的表达。
J Pathol. 1996 Aug;179(4):381-5. doi: 10.1002/(SICI)1096-9896(199608)179:4<381::AID-PATH603>3.0.CO;2-X.
2
Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.肝素结合表皮生长因子样生长因子异构体及表皮生长因子受体/ErbB1在膀胱癌中的表达及其与临床结局的关系
Cancer. 2007 May 15;109(10):2016-24. doi: 10.1002/cncr.22627.
3
Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.ErbB家族受体在原发性膀胱移行细胞癌中的表达谱与预后
Clin Cancer Res. 2001 Jul;7(7):1957-62.
4
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.膀胱移行细胞癌中过表达ErbB2、ErbB3或特定ErbB4亚型患者的鉴定:来自癌症患者的ErbB受体状态评估中的实时逆转录PCR分析
Clin Cancer Res. 2003 Nov 1;9(14):5346-57.
5
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.血吸虫病相关的、器官局限型、肌层浸润性膀胱癌:凋亡标志物、增殖标志物、p53、E-钙黏蛋白、表皮生长因子受体及c-erbB-2的预后价值
J Urol. 2001 May;165(5):1481-7.
6
Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.抗表皮生长因子受体抗体促进ErbB2/ErbB3异二聚体形成从而刺激非小细胞肺癌细胞系生长。
Mol Cancer Res. 2007 Apr;5(4):393-401. doi: 10.1158/1541-7786.MCR-06-0303.
7
Expression of the epidermal growth factor receptor family in normal and malignant urothelium.表皮生长因子受体家族在正常和恶性尿路上皮中的表达。
BJU Int. 2005 Jun;95(9):1344-50. doi: 10.1111/j.1464-410X.2005.05497.x.
8
Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.c-myc蛋白的表达与移行细胞膀胱癌中的细胞增殖及生长因子受体的表达相关。
J Pathol. 1995 Feb;175(2):203-10. doi: 10.1002/path.1711750208.
9
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.表皮生长因子和β细胞素通过共同表达的ErbB2和ErbB3受体介导信号转导。
EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608.
10
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.表皮生长因子受体及肿瘤细胞增殖在膀胱癌中的预后价值:治疗意义
Urol Oncol. 2004 Mar-Apr;22(2):93-101. doi: 10.1016/j.urolonc.2004.01.001.

引用本文的文献

1
Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations.胃癌中 MMP-2 和 MMP-9 与 Her2/neu 过表达的关系研究:临床病理相关性。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):811-817. doi: 10.31557/APJCP.2021.22.3.811.
2
Upregulation of ADAMTS‑7 and downregulation of COMP are associated with aortic aneurysm.ADAMTS-7 的上调和 COMP 的下调与主动脉瘤有关。
Mol Med Rep. 2017 Oct;16(4):5459-5463. doi: 10.3892/mmr.2017.7293. Epub 2017 Aug 21.
3
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
食管胃交界腺癌中基质金属蛋白酶-9、基质金属蛋白酶-2及其抑制剂金属蛋白酶组织抑制因子-1和金属蛋白酶组织抑制因子-2的评估
Onco Targets Ther. 2016 Jul 18;9:4343-9. doi: 10.2147/OTT.S99580. eCollection 2016.
4
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.肽疫苗和针对 HER 和 VEGF 蛋白的靶向治疗可能为癌症免疫治疗提供一个潜在的新模式。
Future Oncol. 2012 Aug;8(8):961-87. doi: 10.2217/fon.12.95.
5
Expression of NRG1 and its receptors in human bladder cancer.NRG1 及其受体在人膀胱癌中的表达。
Br J Cancer. 2011 Mar 29;104(7):1135-43. doi: 10.1038/bjc.2011.39. Epub 2011 Mar 1.
6
Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.比较全球与表皮生长因子受体通路谱分析预测膀胱癌对拉帕替尼的敏感性。
Neoplasia. 2009 Nov;11(11):1185-93. doi: 10.1593/neo.09898.
7
Management of bladder cancer: current and emerging strategies.膀胱癌的管理:当前及新出现的策略
Drugs. 2009 Jun 18;69(9):1173-87. doi: 10.2165/00003495-200969090-00003.
8
The ERBB3 receptor in cancer and cancer gene therapy.癌症中的ERBB3受体与癌症基因治疗
Cancer Gene Ther. 2008 Jul;15(7):413-48. doi: 10.1038/cgt.2008.15. Epub 2008 Apr 11.
9
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.ErbB家族受体独特的表达模式表明膀胱癌存在侵袭性变异型。
J Urol. 2008 Jan;179(1):353-8. doi: 10.1016/j.juro.2007.08.087. Epub 2007 Nov 19.
10
The ErbB signaling network: receptor heterodimerization in development and cancer.表皮生长因子受体(ErbB)信号网络:发育与癌症中的受体异二聚化
EMBO J. 2000 Jul 3;19(13):3159-67. doi: 10.1093/emboj/19.13.3159.